Martin Andreas Bopp
Bayer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Martin Andreas Bopp.
Proteomics | 2002
Michael Pawlak; Eginhard Schick; Martin Andreas Bopp; Michael J. Schneider; Peter Oroszlan; Markus Ehrat
Protein microarrays are considered an enabling technology, which will significantly expand the scope of current protein expression and protein interaction analysis. Current technologies, such as two‐dimensional gel electrophoresis (2‐DE) in combination with mass spectrometry, allowing the identification of biologically relevant proteins, have a high resolving power, but also considerable limitations. As was demonstrated by Gygi et al. (Proc. Nat. Acad. Sci. USA 2000, 97, 9390–9395) [1], most spots in 2‐DE, observed from whole cell extracts, are from high abundance proteins, whereas low abundance proteins, such as signaling molecules or kinases, are only poorly represented. Protein microarrays are expected to significantly expedite the discovery of new markers and targets of pharmaceutical interest, and to have the potential for high‐throughput applications. Key factors to reach this goal are: high read‐out sensitivity for quantification also of low abundance proteins, functional analysis of proteins, short assay analysis times, ease of handling and the ability to integrate a variety of different targets and new assays. Zeptosens has developed a revolutionary new bioanalytical system based on the proprietary planar waveguide technology which allows us to perform multiplexed, quantitative biomolecular interaction analysis with highest sensitivity in a microarray format upon utilizing the specific advantages of the evanescent field fluorescence detection. The analytical system, comprising an ultrasensitive fluorescence reader and microarray chips with integrated microfluidics, enables the user to generate a multitude of high fidelity data in applications such as protein expression profiling or investigating protein‐protein interactions. In this paper, the important factors for developing high performance protein microarray systems, especially for targeting low abundant messengers of relevant biological information, will be discussed and the performance of the system will be demonstrated in experimental examples.
Analytica Chimica Acta | 2002
Gert Ludwig Duveneck; Andreas P. Abel; Martin Andreas Bopp; Gerhard M. Kresbach; Markus Ehrat
Abstract In the first part of this paper, the need for analytical techniques capable of highly parallel and sensitive nucleic acid analysis, with the capability of achieving very low limits of detection (LODs) and of resolving small differences in concentration, is described. Whereas the requirement for performing simultaneously multi-analyte detection is solved by the approach of nucleic acid microarrays, requirements on sensitivity can often not be satisfied by classical detection technologies. Inherent limitations of conventional fluorescence excitation and detection schemes are identified, and the implementation of planar waveguides as analytical platforms for nucleic acid microarrays, with fluorescence excitation in the evanescent field associated with the guided excitation light, is proposed. The relevant parameters for an optimization of sensitivity are discussed. In the second part of this paper, the specific formats of our planar waveguide platforms, which are compatible with established industrial standard formats allowing for integration into industrial high throughput environments, are presented, as well as the dedicated optical system for fluorescence excitation and detection that we developed. In a direct comparison with a state-of-the-art scanner, it is demonstrated that the implementation of genomic microarrays on planar waveguide platforms allows for unprecedented, direct detection of low-abundant genes in limited amounts of sample. Otherwise, when using conventional fluorescence excitation and detection configurations, the detection of such low amounts of nucleic acids requires massive sample preparation and signal or target amplification steps.
Archive | 2001
Michael Pawlak; Eginhard Schick; Andreas P. Abel; Gert Ludwig Duveneck; Markus Ehrat; Gerhard M. Kresbach; Eveline Schürmann-Mader; Martin Andreas Bopp
Archive | 2001
Michael Pawlak; Markus Ehrat; Gert Ludwig Duveneck; Martin Andreas Bopp
Archive | 2001
Wolfgang Zesch; Martin Andreas Bopp; Michael Pawlak
Archive | 2000
Eveline Schürmann-Mader; Andreas Peter Abel; Martin Andreas Bopp; Gert Ludwig Duveneck; Markus Ehrat; Gerhard Matthias Kresbach; Michael Pawlak; Nania G. Schärer-Hernandez; Eginhard Schick
Archive | 2001
Gert Ludwig Duveneck; Martin Andreas Bopp; Michael Pawlak; Markus Ehrat
Archive | 2002
Gert Ludwig Duveneck; Martin Andreas Bopp; Michael Pawlak; Markus Ehrat; Gerd Marowsky
Archive | 2002
Tilo Callenbach; Max Gmür; Heinz Lüthi; Martin Andreas Bopp; Michael Pawlak; Markus Ehrat
Archive | 2002
Martin Andreas Bopp; Heinrich Büttgen; Tilo Callenbach; Werner Schoch; Yves Marmier; André Marcel Wicky